Kusuri No Aoki Holdings Lifts Q3 Revenue Amid Expansion, But Next-Year Outlook Points to Slower Growth
Kusuri No Aoki Holdings Co., Ltd. (TSE:3549), a leading drugstore operator in the Hokuriku region of Japan, reported a 13.7% year-over-year (YoY) increase in revenue for its third quarter of fiscal year 2026, reaching JPY 422.8bn. The company also saw operating profit rise by 7.4% to JPY 21.4bn, with net profit growing by 10.3% to JPY 15.4bn. Despite these gains, management has provided a mixed outlook for the coming fiscal year, projecting revenue growth to JPY 560bn but expecting operating profit and net profit to decline.
Key Numbers
| Metric | Q3 2026 (JPY bn) | YoY Change |
|---|---|---|
| Revenue | 422.8 | +13.7% |
| Operating Profit | 21.4 | +7.4% |
| Ordinary Income | 21.8 | +6.6% |
| Net Profit | 15.4 | +10.3% |
| Operating Margin | 5.1% | — |
| Equity Ratio | 35.7% | — |
Business Overview
Kusuri No Aoki Holdings is a mid-sized drugstore operator with a strong presence in the Hokuriku region, where it holds the top market position. The company's core business model centers on pharmacy-operated stores, with expansion into food and essential goods. It has been actively growing its footprint through new store openings and strategic acquisitions.
Analysis
Kusuri No Aoki's 13.7% YoY revenue growth reflects the success of its expansion strategy, particularly in increasing the number of pharmacies and food departments within its stores. The company opened 71 new stores and 35 new pharmacies in the third quarter, reinforcing its "food and drug" one-stop shopping model. Additionally, the acquisition of Mihashoten, a food supermarket operator, has strengthened its food division and diversified its revenue streams.
Despite the revenue growth, the operating margin of 5.1% remains in line with industry averages, suggesting that cost management and profit improvement have not yet accelerated. While net profit rose by 10.3%, the growth was slightly lagging behind the revenue increase, indicating that the company is still working on improving its overall profitability.
The equity ratio has declined to 35.7% from 41.4% in the previous period, signaling a potential increase in debt reliance, which could be a concern for long-term financial stability.
## Next Year Guidance
Management has provided guidance for the next fiscal year, with the following expectations:
| Metric | Next Year Guidance (JPY bn) | YoY Change vs. FY2026 Actual |
|---|---|---|
| Revenue | 560.0 | +11.7% |
| Operating Profit | 23.0 | -13.5% |
| Ordinary Income | 22.7 | -17.5% |
| Net Profit | 15.5 | -12.9% |
The guidance reflects a mixed outlook: revenue is expected to grow by 11.7% to JPY 560bn, while operating profit and net profit are projected to decline by 13.5% and 12.9%, respectively. This reflects the company's continued expansion ambitions alongside margin pressure from competitive and cost headwinds.
What to Watch
-
Sustained Growth in Food and Pharmacy Integration: The company’s success in expanding its food and pharmacy model has been a key driver of revenue growth. Continued execution of this strategy will be critical to maintaining momentum.
-
Profitability Improvements: While revenue is growing, the operating margin remains flat. Management will need to focus on cost control and operational efficiency to improve profitability in the coming year.
-
Debt Management and Equity Ratio: The decline in the equity ratio to 35.7% raises concerns about the company’s capital structure. Investors should monitor how the company manages its debt and whether it can maintain financial stability amid slower growth.
As Kusuri No Aoki navigates a more challenging environment, its ability to balance expansion with profitability will be a key determinant of its future performance.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.